Article Text
Abstract
The success of digital COVID-19 contact tracing requires a strategy that successfully addresses the digital divide—inequitable access to technology such as smartphones. Lack of access both undermines the degree of social benefit achieved by the use of tracing apps, and exacerbates existing social and health inequities because those who lack access are likely to already be disadvantaged. Recently, Singapore has introduced portable tracing wearables (with the same functionality as a contact tracing app) to address the equity gap and promote public health. We argue that governments have an ethical obligation to ensure fair access to the protective benefits of contract tracing during the pandemic and that wearables are an effective way of addressing some important equity issues. The most contentious issues about contact tracing apps have been the potential infringements of privacy and individual liberty, especially where the use of apps or other technology (such as wearables or QR codes) is required for access to certain spaces. Here we argue that wearables, as opposed to apps alone, will make a digital contact tracing mandate more practical and explain some conditions under which such a mandate would be justified. We focus on Singapore as a case study that has recently deployed contact tracing wearables nationally, but also reference debate about wearables in Australia and New Zealand. Our analysis will be relevant to counties trialling similar portable tracing wearables.
- confidentiality/privacy
- information technology
- public health ethics
- social control of science/technology
- COVID-19
Data availability statement
There are no data in this work
This article is made freely available for personal use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.
https://bmj.com/coronavirus/usageStatistics from Altmetric.com
- confidentiality/privacy
- information technology
- public health ethics
- social control of science/technology
- COVID-19
Data availability statement
There are no data in this work
Footnotes
Twitter @G_Owen_Schaefer
Contributors This paper was conceived by GOS. Its content was decided after discussion by GOS and AB, with GOS providing the initial draft and GOS and AB subsequently discussing and iterating edits and comments on subsequent drafts.
Funding This paper was supported in part by a grant from the Social Science Research Council (Ministry of Education, Singapore): MOE2017-SSRTG-028.
Competing interests None declared.
Provenance and peer review Not commissioned; externally peer reviewed.
Read the full text or download the PDF:
Other content recommended for you
- How to fairly incentivise digital contact tracing
- Effectiveness of Ehteraz digital contact tracing app versus conventional contact tracing in managing the outbreak of COVID-19 in the State of Qatar
- Without a trace: Why did corona apps fail?
- Analysis of the factors affecting the adoption and compliance of the NHS COVID-19 mobile application: a national cross-sectional survey in England
- Adoption and continued use of mobile contact tracing technology: multilevel explanations from a three-wave panel survey and linked data
- Effectiveness of contact tracing apps for SARS-CoV-2: a rapid systematic review
- The way forward after COVID-19 vaccination: vaccine passports with blockchain to protect personal privacy
- Lessons from countries implementing find, test, trace, isolation and support policies in the rapid response of the COVID-19 pandemic: a systematic review
- Developing digital contact tracing tailored to haulage in East Africa to support COVID-19 surveillance: a protocol
- Applications and challenges of AI-based algorithms in the COVID-19 pandemic